Humira and Oedema peripheral - a phase IV clinical study of FDA data

Summary:

Oedema peripheral is found among people who take Humira, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Humira and have Oedema peripheral. It is created by eHealthMe based on reports of 647,817 people who have side effects when taking Humira from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 25, 2023

647,817 people reported to have side effects when taking Humira.
Among them, 5,853 people (0.9%) have Oedema peripheral.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 650,663 Humira users for its effectiveness, alternative drugs and more.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 3,603 drugs and 3,400 conditions by eHealthMe.

Number of Humira and Oedema peripheral reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Humira and have Oedema peripheral?

Check whether Oedema peripheral is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .

Related studies

How severe was Oedema peripheral and when was it recovered:

Oedema peripheral in Humira

Expand to all the drugs that have ingredients of adalimumab:

Oedema peripheral and drugs with ingredients of adalimumab

Alternative drugs to, pros and cons of Humira:

Humira (650,663 reports)

Common Humira side effects:

Drug ineffective: 93,489 reports
Joint pain: 47,464 reports
Pain: 47,288 reports
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 39,149 reports
Fatigue (feeling of tiredness): 38,407 reports
Rashes (redness): 32,791 reports
Diarrhea: 27,396 reports

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oedema peripheral treatments and more:

Oedema peripheral (158,983 reports)

COVID vaccines that are related to Oedema peripheral:

Common drugs associated with Oedema peripheral:

All the drugs that are associated with Oedema peripheral:

Oedema peripheral (3,603 drugs)

Common conditions associated with Oedema peripheral:

High blood pressure: 10,901 reports
Rheumatoid arthritis: 9,825 reports
Primary pulmonary hypertension: 7,964 reports
Pain: 6,039 reports
Osteoporosis: 5,018 reports
Multiple myeloma: 4,416 reports

All the conditions that are associated with Oedema peripheral:

Oedema peripheral (3,400 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.